Epocrates to Present at the JMP Securities Healthcare Conference on September 28, 2011

San Mateo, Calif., September 21, 2011

SAN MATEO, Calif., Sept. 21, 2011 (GLOBE NEWSWIRE) -- Epocrates, Inc. (Nasdaq:EPOC), a leading provider of mobile drug reference tools to healthcare professionals and interactive services to the healthcare industry, today announced that Rose Crane, president and chief executive officer, is scheduled to present at the JMP Securities Healthcare Conference at 11:00 a.m. Eastern Time on Wednesday, September 28, 2011, at the St. Regis Hotel located at 2 East 55th Street, New York, NY.

To access the simultaneous webcast, go to the Investor Relations section of Epocrates' website at http://investor.epocrates.com and click on the webcast icon. The webcast will also be available for replay approximately one hour after the presentation is complete.

About Epocrates, Inc.

Epocrates, Inc. (Nasdaq:EPOC), developers of the #1 most used mobile medical app among U.S. physicians, creates point-of-care digital solutions that enhance the practice of medicine. More than 1.3 million healthcare professionals, including 50 percent of U.S. physicians, use Epocrates' solutions to help improve patient care and practice efficiencies with its drug reference, educational and clinical apps. The new Epocrates mobile and web-based EHR solution, designed for solo and small practice physicians, is affordable, easy-to-use and further supports physician workflow and patient outcomes. The company also partners with the healthcare industry, including top pharmaceutical companies, to engage with its clinician network through effective, interactive services. For more information about Epocrates, please visit www.epocrates.com/company.

Epocrates is a trademark of Epocrates, Inc., in the U.S. and other countries.

Media Contact

Holly Spring
athenahealth, Inc. (Media)
media@athenahealth.com
617-402-1631

Dana Quattrochi
athenahealth, Inc. (Investors)
investorrelations@athenahealth.com
617-402-1329

April Marks
Epocrates, Inc. (Media)
pr@epocrates.com
650-520-2413